How quickly do people lose weight on Wegovy — and what shapes the timeline?

You've just started, and nothing seems to be happening yet

It's a familiar experience. You've taken your first pen, you're paying close attention, and the scale hasn't moved much. That's expected, and it doesn't mean the medicine isn't working.

The opening weeks of Wegovy are spent at 0.25mg, a tolerability dose whose job is to let your body adjust to the medicine, not to produce immediate weight loss. Appetite suppression is the first signal most people notice, often before the scale reflects it. Portion sizes shrink naturally. Meals that used to feel necessary start feeling optional. The weight usually follows.

By weeks four to eight, many people are moving toward higher doses and seeing measurable changes. The STEP 1 trial published in the New England Journal of Medicine found that meaningful weight reduction was underway for most participants well before the 68-week endpoint, but the curve was gradual, not dramatic. A quick check you can do right now: weigh yourself at the same time of day, without clothes, and log it as your starting reference point. That single number, repeated weekly under the same conditions, gives you far more useful data than daily fluctuations on a random scale.

If you want a more detailed look at the early weeks specifically, the full breakdown of how long Wegovy takes to work covers what typically happens at each titration stage.

The middle stretch, where most of the loss happens

For the majority of people in the STEP 1 trial, the steepest period of weight loss fell roughly between months three and nine. This is the window when dose titration (moving from 0.5mg through 1.0mg and 1.7mg toward the 2.4mg maintenance dose) is usually progressing, and the medicine's appetite effects are at their most pronounced.

The mechanism is a single pathway: semaglutide activates GLP-1 receptors in the gut and brain, slowing how quickly the stomach empties and signalling fullness more persistently. The result, for most people, is that food becomes less central to the day. Cravings flatten. Meals become smaller without effort. That shift, sustained over months, is where the 15% average loss comes from.

It's worth understanding what 15% looks like in practice. For someone starting at 100kg, that's 15kg over roughly 16 months. For someone at 130kg, it's around 19.5kg. The NICE appraisal of semaglutide (TA875) uses a threshold of 5% weight loss after six months at the highest tolerated dose as the minimum expected response, below that, a prescriber should review whether continuing is appropriate.

Lifestyle factors matter throughout this phase. Wegovy is licensed alongside a reduced-calorie diet and increased physical activity; the trial participants received structured support alongside the medicine. People who keep protein intake steady and maintain some form of regular movement tend to report better outcomes, though personal plans are something to discuss with your prescriber or a dietitian rather than something to guess at alone.

For context on how Wegovy sits within the broader range of weight-loss treatments, the treatment overview page explains the options currently available.

What to expect after you reach maintenance dose

Weight loss on Wegovy doesn't plateau immediately once someone reaches 2.4mg. In the STEP 1 trial, participants continued losing weight through much of the second year, though the rate slowed as body weight stabilised. If you're curious about how fast people lose weight on Wegovy at each stage of treatment, the picture varies more than the headline average suggests. The average loss at week 68 was around 15%, meaning the final months contributed meaningfully to the total, even if progress felt slower day to day.

The newer 7.2mg dose, approved by the MHRA in early 2026, shows higher average losses in trials: around 20.7% over 72 weeks. That figure is encouraging, but it applies to a different licensed dose and a different titration pathway, and it doesn't mean every person reaches that number. Understanding how quickly you lose weight on Wegovy depends on factors including starting weight, dose progression and how well individual side effects are tolerated. The MHRA approved a dedicated single-dose 7.2mg pen in April 2026 for adults with a BMI of 30 or above; specific dose availability is confirmed at consultation, not assumed in advance. You can read more about Wegovy's licensed uses and dosing schedule in full.

Some people worry that stopping Wegovy leads to regaining everything lost. The trial evidence broadly supports that concern, weight tends to return over time after stopping, which is why our page on how long people take Wegovy is one of the resources our prescribers most often point patients toward. NICE's guidance for the NHS allows semaglutide for a maximum of two years within a specialist weight management service; private prescribing has its own clinical framework, reviewed at each repeat. That's not a small distinction, and it's worth understanding before you start.

If you're weighing up how your situation fits the eligibility criteria or thinking about what a supervised programme looks like in practice, our prescribers can walk through that properly. This is a prescription medicine, the timeline it produces depends on the clinical picture, not just the average from a trial. Start your free consultation and a GPhC-registered prescriber will review your information the same day.